Company intelligence / Profile preview

Clean Cells

Western France, Franceclean-cells.com ↗
Ownership
Private
Employees
~100
Development stage
Commercial
01

Overview

Clean Cells does not have its own clinical pipeline. It provides GMP-compliant safety testing, cell and virus banking, process development, and quality control services to biopharmaceutical clients developing innovative therapies including biologics, vaccines, gene therapies, and cell therapies.

Modalities
BiologicCell therapyVirus-based therapyVaccineRecombinant proteinGene therapy vector
Industry
Contract Manufacturing Organization
02

Partnerships

Sister company Naobios within the same group for virus-based product development/manufacturemember of Atlanpole Biotherapy cluster

Beyond the preview

Go deeper on Clean Cells.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clean Cells.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call